Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C31H40N6O7S |
| Molecular Weight | 640.75 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CCCCNC=O)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3CCSC3=O
InChI
InChIKey=RQBSKKBNALPMSL-QUMGSSFMSA-N
InChI=1S/C31H40N6O7S/c32-23(16-21-9-11-22(39)12-10-21)28(41)36-24(8-4-5-14-33-19-38)29(42)34-18-27(40)35-26(17-20-6-2-1-3-7-20)30(43)37-25-13-15-45-31(25)44/h1-3,6-7,9-12,19,23-26,39H,4-5,8,13-18,32H2,(H,33,38)(H,34,42)(H,35,40)(H,36,41)(H,37,43)/t23-,24+,25+,26-/m0/s1
| Molecular Formula | C31H40N6O7S |
| Molecular Weight | 640.75 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ociltide (also known as Hoe 825), an enkephalin peptide that via inhibition of the inhibitory nervous system could influence on esophageal motility, fundic accommodation to distention, and migrating myoelectric complex. Information about the current development of this drug is not available.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3582898
40 micrograms i.v.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:31 GMT 2025
by
admin
on
Mon Mar 31 18:48:31 GMT 2025
|
| Record UNII |
G150413778
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C681
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5560
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
78410-57-8
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
G150413778
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104422
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
76965368
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
DTXSID70868477
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
SUB09397MIG
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
C84025
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY | |||
|
100000083838
Created by
admin on Mon Mar 31 18:48:31 GMT 2025 , Edited by admin on Mon Mar 31 18:48:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |